Compare Becton Dickinson and Co (BDX) vs Crowdstrike Holdings Inc (CRWD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Crowdstrike Holdings Inc — how do they compare? Becton Dickinson and Co trades at $182.63 (market cap $50.00B), while Crowdstrike Holdings Inc trades at $225 (market cap $225.83B). The key difference: Crowdstrike Holdings Inc is far larger — about 4.5× Becton Dickinson and Co's market cap, and Becton Dickinson and Co pays a 2.29% dividend while Crowdstrike Holdings Inc pays none. Which is the better fit depends on your goals.
| BDX | CRWD | |
|---|---|---|
Market Cap | $50.00B | $225.83B |
Sector | Health | Technology |
52-Week High | $185.39 | $225.16 |
52-Week Low | $138.62 | $87.56 |
Enterprise Value | $66.10B | $222.10B |
Dividend Yield | 2.29% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $181.97, up 0.31% with a bullish technical signal from moving averages. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results showing 4.4% FX-neutral revenue growth to $5 billion. Analyst consensus is mixed with 47% buy ratings and a $183 price target, while strong cash flow generation supports dividend payments of $1.05 quarterly.
BDX demonstrates solid fundamental performance with consistent revenue growth and dividend reliability, though net margins remain compressed at 4.19%. Key risks include tariff pressures and competitive market dynamics. The stock trades near analyst targets with balanced institutional sentiment suggesting moderate upside potential amid ongoing operational execution.
CrowdStrike (CRWD) trades at $225.53, up 1.64% today, near its all-time high with a bullish technical trend. The stock has delivered three consecutive quarterly EPS beats, with Q1 2026 actual EPS of $0.28 exceeding the $0.27 estimate. Revenue growth remains robust, reaching $3.95 billion in 2025, though net income margins are negative at -0.6%. A 1:4 stock split occurred on July 2, 2026, enhancing accessibility. Operating cash flow strengthened to $1.38 billion in 2025, supporting ongoing investments in AI security expansions like Project QuiltWorks.
Outlook: Strong revenue growth and market leadership in cybersecurity present upside, but extreme valuations (P/E of 765, P/S of 44) heighten sensitivity to earnings misses. Risks include competitive pressures and high expectations priced into the stock. Analyst consensus is bullish with 76% buy ratings, though the $192.74 average target suggests caution near current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Crowdstrike Holdings Inc
CrowdStrike Holdings provides cybersecurity products and services aimed at protecting organizations from cyberthreats. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, identity protection, and log management. CrowdStrike went public in 2019 and serves customers worldwide.
Read more on CRWD →
